Dupilumab 200mg, 300mg Injection — Anti-IL-4/IL-13 Monoclonal Antibody for Atopic Dermatitis, Severe Asthma, Chronic Rhinosinusitis With Nasal Polyps, Eosinophilic Oesophagitis, Prurigo Nodularis and COPD With Type 2 Inflammation
Tremelimumab 300mg Injection — Anti-CTLA-4 Monoclonal Antibody Used in Combination With Imfinzi (Durvalumab) for Unresectable Hepatocellular Carcinoma and Extensive-Stage Small Cell Lung Cancer